Operationalizing Precision Medicine: How U.S. Health Systems Are Implementing Genetic Testing

To better understand how health systems are operationalizing precision medicine and genetic testing programs today, the Institute for Precision Medicine at UPMC and the University of Pittsburgh partnered with KLAS Research and the Center for Connected Medicine (CCM) at UPMC to survey health care leaders from midsize and large U.S. health systems. This work builds on the Institute for Precision Medicine’s broader efforts — led in part by experts like Dr. Mylynda Massart — to advance the integration of genomics into clinical care.

The findings build upon past CCM research published in 2020 that assessed health system’s early efforts to build precision medicine programs.

The new report shares the current state of precision medicine program maturity, common use cases, barriers, funding approaches, integration patterns, and equity strategies, along with leaders’ expectations for precision medicine over the next five years.

While progress has been made since the 2020 research, it is clear that more work is needed, especially when it comes to stable and consistent funding, for health care to fully realize the promise of precision medicine.

Download the report.